Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease

Substituted pyrido[1,2-a]pyrazines and substituted pyrido[1,2-a][1,4]diazepines for the treatment of (inter alia) Alzheimer's disease

US Patent 9181245 · Granted Nov 10, 2015

Estimated economic value: $61,989,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted quinazolines as HDAC6 inhibitors2025
Combinations comprising positive allosteric modulators or orthosteric agonists o2024
Tau PET imaging ligands2024
Combinations comprising positive allosteric modulators or orthosteric agonists o2022
[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors2022
[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors2022
[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors2022
Tau PET imaging ligands2021
Combinations comprising positive allosteric modulators or orthosteric agonists o2021
1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones2021
1′,3′-disubstituted-4-phenyl-3,4,5,6-tetrahydro-2H,1′H-[1,4′]bipyridinyl-2′-ones2021
[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors2021